This page is an unofficial mirror and is not legal advice. Verify the document against the official source before relying on it.
SB477: relative to increasing transparency in the 340B Drug Pricing Program.
Bill details
No mirrored bill text is available for this bill yet. Use the official source links below for the full current record.
Version history, amendments, and roll-call votes were not present in the imported local bill data.
Official links
SB477: relative to increasing transparency in the 340B Drug Pricing Program.
Related law links
RSA references from bill data
-
126-A
· amend
· effective 2027-01-01
nvened: 1 Short Title. This act shall be known as the "Sunshine in Savings Act". 2 New Subdivision; 340B Drug Pricing Program; Reporting and Claims Identification. Amend RSA 126-A by inserting after section 106 the following new subdivision: 340B Drug Pricing Program; Reporting and Claims Identification 126-A:107 Definitions. In this subdivision: I. “340B covered entity” has the same meanin
-
358-A
· reference
· effective 2027-01-01
e department may adopt rules under RSA 541-A regarding the requirements of this subdivision. II. Material non-filing or false filing constitutes an unfair or deceptive act under RSA 358-A and any right or remedy under RSA 358-A may be used to enforce this subdivision. 126-A:114 Severability. If any section, provision, or portion of this subdivision, including any condition or prerequisite to any actio
-
541-A
· reference
· effective 2027-01-01
l not include ceiling prices, unit rebate amounts, or drug-specific proprietary pricing. 126-A:113 Rulemaking; Compliance; Enforcement. I. The department may adopt rules under RSA 541-A regarding the requirements of this subdivision. II. Material non-filing or false filing constitutes an unfair or deceptive act under RSA 358-A and any right or remedy under RSA 358-A may be used to enforce this subdiv